TARS

NASDAQ HEALTHCARE

Tarsus Pharmaceuticals Inc

$58.60

$0.08 (+0.14%)

Live quote

52w: $38.51 – $85.25

Loading chart…

P/E Ratio—

P/B Ratio7.22

EV/EBITDA—

Debt/Equity—

ROE-19.03%

ROIC—

Revenue Growth146.71%

Gross Margin—

Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new therapeutic candidates for ophthalmic conditions. The company is headquartered in Irvine, California.

Own TARS? Track it here.

Create a free account to add TARS to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account